Financials
Income statement
Fiscal date | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total reported revenue | 18.2B | 16.3B | 15.8B | 13.9B |
Cost of revenue | 14.4B | 12.7B | 12.2B | 10.4B |
Gross profit | 3.8B | 3.6B | 3.6B | 3.4B |
Operating expense | ||||
Research & development | 987M | 768M | 768M | 748M |
Selling general and admin | 2.0B | 1.8B | 1.7B | 1.5B |
Other operating expenses | -38M | -102M | -1M | -81M |
Operating income | 876M | 1.1B | 996M | 1.2B |
Non operating interest income | ||||
Income | 53M | — | 30M | 30M |
Expense | 343M | 197M | 124M | 126M |
Other income expense | — | — | — | — |
Pretax income | 3M | 576M | 852M | 1.1B |
Tax provision | 608M | 240M | 268M | 348M |
Net income | -605M | 335M | 585M | 775M |
Basic EPS | -0.9 | 0.5 | 0.8 | 1.1 |
Diluted EPS | -0.9 | 0.5 | 0.8 | 1.1 |
Basic average shares | 736M | 666M | 666M | 666M |
Diluted average shares | 736M | 666M | 666M | 666M |
EBITDA | 2.0B | 1.9B | 1.9B | 2.2B |
Net income from continuing op. | 294M | 834M | 974M | 1.2B |
Minority interests | -27M | -26M | -27M | -19M |
Preferred stock dividends | 0 | 0 | 0 | 0 |